Most supplement, skincare and haircare manufacturers require new technologies and formulas in order to operate, maintain their market share and grow.   Due to cost and scalability investing into R&D is not prohibited. For a majority of manufacturers, transfer of technology (TOT) via licensing is a key growth strategy. Domestically, TOT accounts for $700 billion of business each year. Each year businesses invest over $600 billion in capital goods and licensing. This highlights that businesses can invest in capital goods i.e. a transfer of technology while managing their balance sheets, taxes, cash flow and growth strategy.

The assets that a business may need to acquire or finance for new product innovation varies. Here are examples relevant to BIOFARV’s technology and value proposition;

Regulatory Compliance: Compliance with existing permits and manufacturing requirements

Human Capital: Engineers and Scientists to R&D new formulas, batching and product testing

Equipment:  Procurement of new equipment and compliance

Liabilities:  Product liabilities and specifications

COMPANY123 + STEM CELLS
repair + regenerate + revitalize

REVOLUTIONIZING THE SKINCARE + HAIRCARE MARKET

TRANSFER OF TECHNOLOGY (TOT) PROCESS

1. FORMULATE IDEAL & MUTUALLY BENEFITING TOT ROUGH DRAFT: + BASED ON BIOFARV STRATEGY AS AN ADDED VALUE TO COMPANY123 EXISTING COMMERCIAL STRUCTURE & MARKET

2. EXECUTE TOT AGREEMENT & CONDITIONS

3. TOT TRANSFER + INTEGRATION COLLABORATION: PERTURBATION PRODUCT BENCHMARK

4. NEW PRODUCT FINALIZATION – SMART TESTING + BATCHING

5. COORDINATION & SUPPLY OF BATCHING

6. TECHNICAL MARKETING SUPPORT

7. TOT COMPLIANCE & SECURITY